Gabather

About Gabather

Gabather AB is a Swedish pharmaceutical company focused on developing innovative treatments for central nervous system disorders, such as schizophrenia and depression. The company develops drugs that affect the GABA system in the brain, with the goal of offering new therapies with better efficacy and fewer side effects. Gabather was founded in 2014 and is headquartered in Södertälje.

Kategori

All

Hot Chair

An illustration of a human brain

2023-12-11

Hot Chair - Gabather

Michael-Robin Witt, CEO, enlightens potential partnerships based on preliminary study results of their drug candidate GT-002.

Witt highlighted plans for GT-002, aiming for development and commercialization post-Phase 2 studies, and concluded by outlining Gabather's main objectives for 2024. He also comments the ongoing rights issue where they raise 28.6 MSEK.

Read more
Read more

Select your language:

Engelsk flag
EN
Tysk flag
SE